Natus Medical reported $6.14M in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abiomed ABMD:US $ 66.2M 3.4M
Accuray ARAY:US $ 14.09M 9.66M
Atricure ATRC:US $ -15077000 808K
Boston Scientific BSX:US $ 576M 203M
Cardiovascular Systems CSII:US $ -4909000 740K
Cooper Companies COO:US $ 100.6M 48.6M
Cryolife CRY:US $ 4.72M 1.78M
Edwards Lifesciences EW:US $ 544.5M 154.6M
General Electric GE:US $ 758M 100M
Genmark Diagnostics GNMK:US $ -2087000 821K
Globus Medical GMED:US $ 59.75M 5.02M
Hill Rom HRC:US $ 108.7M 21.7M
Inogen INGN:US $ 19.75M 22.15M
Insulet PODD:US $ 26.3M 10M
Integra Lifesciences IART:US $ 71.25M 13.35M
Koninklijke Philips PHG:US 445M 1000K
Masimo MASI:US $ 65.14M 528K
Medtronic MDT:US $ 896M 1101M
Mesa Laboratories MLAB:US $ 3.12M 1.26M
Natus Medical BABY:US $ 6.14M 1.41M
Orthofix International OFIX:US $ 7.85M 9.76M
Perkinelmer PKI:US $ 323.32M 164.31M
Philips PHIA:NA 444M 140M
Surmodics SRDX:US $ -1923000 11.41M
Tandem Diabetes Care TNDM:US $ 5.43M 8.67M
Thermo Fisher Scientific TMO:US $ 2282M 805M
Trinity Biotech TRIB:US 6.29M 3.21M